ClinConnect ClinConnect Logo
Search / Trial NCT04765189

Evaluation of Mangoselect® in Improvement of Exercise/Activity-induced Knee Joint Discomfort in Subjects Suffering From Osteoarthritis Grade I or II

Launched by FYTEXIA · Feb 19, 2021

Trial Information

Current as of June 05, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Physically active volunteers
  • BMI 22-29.9 kg/m2
  • Declaring knee joint pain during and/or after activity/exercise
  • Joint knee pain rated of at least 4 cm on a 10 cm VAS following activity/exercise
  • Diagnosed osteoarthritis grade I or II according to Kellgren-Lawrence classification
  • Exclusion Criteria:
  • Diagnosed inflammatory joint disorder or osteoarthritis grade III or more according to Kellgren-Lawrence classification
  • Currentlu chronically taking pain killer drugs or dietary supplement or intra-articular treatment 3 months before selection
  • Anemia
  • Subjects with knee/joint surgery/replacement in the past 10 years
  • Significant injury of the studied knee joint 12 months before selection
  • Unable to carry out functional tests and/or questionnaires
  • Currently participating or having participated in another clinical trial in the 3 previous months
  • Pregnant women and women positive at Beta-HCG serology test
  • Any condition that the investigator believes would interfere with the ability to provide inform consent, or comply with study instructions, or confound the interpretations of the study results, or put the volunteer at undue risk
  • Allergy to one of the component of the supplements

About Fytexia

Fytexia is a pioneering research and development company dedicated to the creation of innovative health solutions through the exploration of natural ingredients. With a strong focus on clinical trials and scientific validation, Fytexia harnesses cutting-edge methodologies to assess the efficacy and safety of its products, aimed at enhancing well-being across various health domains. The company is committed to advancing nutritional science and improving public health outcomes through rigorous research and collaboration with healthcare professionals and academic institutions.

Locations

Murcia, , Spain

Patients applied

0 patients applied

Trial Officials

Pedro Alcaraz

Principal Investigator

UCAM (Universidad Catolica San Antonio de Murcia)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials